Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A conserved annexin A6–mediated membrane repair mechanism in muscle, heart, and nerve
Alexis R. Demonbreun, Elena Bogdanovic, Lauren A. Vaught, Nina L. Reiser, Katherine S. Fallon, Ashlee M. Long, Claire C. Oosterbaan, Michele Hadhazy, Patrick G.T. Page, Prem Raj B. Joseph, Gabrielle Cowen, Alexander M. Telenson, Ammaarah Khatri, Katherine R. Sadleir, Robert Vassar, Elizabeth M. McNally
Alexis R. Demonbreun, Elena Bogdanovic, Lauren A. Vaught, Nina L. Reiser, Katherine S. Fallon, Ashlee M. Long, Claire C. Oosterbaan, Michele Hadhazy, Patrick G.T. Page, Prem Raj B. Joseph, Gabrielle Cowen, Alexander M. Telenson, Ammaarah Khatri, Katherine R. Sadleir, Robert Vassar, Elizabeth M. McNally
View: Text | PDF
Research Article Cardiology Muscle biology

A conserved annexin A6–mediated membrane repair mechanism in muscle, heart, and nerve

  • Text
  • PDF
Abstract

Membrane instability and disruption underlie myriad acute and chronic disorders. Anxa6 encodes the membrane-associated protein annexin A6 and was identified as a genetic modifier of muscle repair and muscular dystrophy. To evaluate annexin A6’s role in membrane repair in vivo, we inserted sequences encoding green fluorescent protein (GFP) into the last coding exon of Anxa6. Heterozygous Anxa6gfp mice expressed a normal pattern of annexin A6 with reduced annexin A6GFP mRNA and protein. High-resolution imaging of wounded muscle fibers showed annexin A6GFP rapidly formed a repair cap at the site of injury. Injured cardiomyocytes and neurons also displayed repair caps after wounding, highlighting annexin A6–mediated repair caps as a feature in multiple cell types. Using surface plasmon resonance, we showed recombinant annexin A6 bound phosphatidylserine-containing lipids in a Ca2+- and dose-dependent fashion with appreciable binding at approximately 50 μM Ca2+. Exogenously added recombinant annexin A6 localized to repair caps and improved muscle membrane repair capacity in a dose-dependent fashion without disrupting endogenous annexin A6 localization, indicating annexin A6 promotes repair from both intracellular and extracellular compartments. Thus, annexin A6 orchestrates repair in multiple cell types, and recombinant annexin A6 may be useful in additional chronic disorders beyond skeletal muscle myopathies.

Authors

Alexis R. Demonbreun, Elena Bogdanovic, Lauren A. Vaught, Nina L. Reiser, Katherine S. Fallon, Ashlee M. Long, Claire C. Oosterbaan, Michele Hadhazy, Patrick G.T. Page, Prem Raj B. Joseph, Gabrielle Cowen, Alexander M. Telenson, Ammaarah Khatri, Katherine R. Sadleir, Robert Vassar, Elizabeth M. McNally

×

Figure 7

Recombinant annexin A6 cap size increases in a dose-dependent fashion, correlating with improved repair capacity.

Options: View larger image (or click on image) Download as PowerPoint
Recombinant annexin A6 cap size increases in a dose-dependent fashion, c...
(A) Myofibers were isolated from Anxa6gfp mice and laser-damaged in the presence of rA6-tdTomato. rA6-tdTomato (shown in red) colocalized with genomically encoded annexin A6GFP (green) at the site of muscle membrane injury (white arrow). (B) rA6-tdTomato cap size increased with increasing concentrations of rA6-tdTomato, 1.3–130 μg/mL. Genomically encoded annexin A6GFP cap size did not change with increasing concentrations of rA6-tdTomato. (C) rA6-tdTomato formed membranous blebs at the site of membrane injury. (D) Dose-dependent reduction of FM 4-64 dye (red) uptake, a marker of membrane injury, with increasing concentrations of recombinant annexin A6. (E) Anxa6gfp mice were crossed with mdx mice to generate mdx mice expressing genomically encoded annexin A6GFP. (F) Dystrophic histopathology is present in Anxa6gfp mdx muscle. Scale bar: 100 μm. (G) Serum creatine kinase (CK) was elevated in Anxa6gfp mdx mice compared to Anxa6gfp controls (n = 7). (H) Increased FM 4-64 dye (red) in injured Anxa6gfp mdx myofibers compared with Anxa6gfp controls. (I and J) In Anxa6gfp mdx myofibers, genomically encoded annexin A6GFP formed a repair cap at the site of membrane injury. rA6-tdTomato cap size increased with increasing concentrations of rA6-tdTomato, 1.3–130 μg/mL. Genomically encoded annexin A6GFP cap size did not change significantly with varying concentrations of rA6-tdTomato in Anxa6gfp mdx myofibers. (K) Increasing concentrations of recombinant annexin A6 resulted in a dose-dependent reduction of FM 4-64 dye (red) uptake in dystrophic myofibers. Scale bar: 5 μm. A total of 4–9 myofibers from n ≥ 4 isolations. *P < 0.05 by 1-way ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts